We are live on ! Find out more
WVE icon

Wave Life Sciences

88 hedge funds and large institutions have $184M invested in Wave Life Sciences in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more call options, than puts

Call options by funds: $633K | Put options by funds: $262K

1% more funds holding

Funds holding: 87 → 88 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

7% more capital inflows, than outflows

Capital inflows: $28M | Capital outflows: $26.2M

0.1% more ownership

Funds ownership: 73.63% → 73.72% (+0.1%)

14% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 29

Holders
88
Holders Change
+1
Holders Change %
+1.15%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
25
Reduced
29
Closed
12
Calls
$633​K
Puts
$262​K
Net Calls
+$371​K
Net Calls Change
-⁠$276​K

WVE Hedge Fund Activity: Q3 2021 in Review

88 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2021, worth a combined $184M — down 26% from $247M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new WVE positions and 12 closed out — a net gain of 1 holder — while 25 added to existing stakes and 29 trimmed.

The largest buyer was Artal Group, opening a new position worth an estimated $6.06M. The largest seller was Deerfield Management, cutting an estimated $9.8M.

  • 88 institutional investors held Wave Life Sciences (WVE) as of Q3 2021, up from 87 in Q2 2021.
  • Funds reported $184M of Wave Life Sciences stock for Q3 2021, down 26% quarter-over-quarter.
  • 13 funds opened new Wave Life Sciences positions in Q3 2021 and 12 closed out, a net change of +1 holder.
  • The largest Wave Life Sciences buyer in Q3 2021 was Artal Group, an estimated $6.06M added.
  • The largest Wave Life Sciences seller in Q3 2021 was Deerfield Management, an estimated $9.8M sold.

Based on aggregated 13F filings for Q3 2021.